Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cellevolve Bio
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cellevolve Bio

Cellevolve Bio

Seed

San Francisco-based cell therapy provider, partnering with global innovators to advance and commercialize novel therapeutics.

HQ
San Francisco, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Cellevolve Bio, founded in San Francisco, is dedicated to revolutionizing health outcomes through the development and commercialization of novel cell therapies. The company partners with global innovators to advance clinical-stage therapies, particularly focusing on neglected diseases. By leveraging technological advances and a collaborative approach, Cellevolve aims to bring innovative treatments from late-stage development to market, addressing unmet medical needs and transforming patient care.

Notable affiliated individuals and investors include leaders and experts in biotechnology and healthcare, though specific names are not provided. Key achievements of Cellevolve Bio include establishing strategic partnerships with academic centers and biotech firms worldwide, driving the advancement of cutting-edge cell therapies. The company's impact lies in its commitment to democratizing innovation and improving health outcomes for patients with diseases that have been historically overlooked.

Cellevolve Bio - Similar Companies

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Celularity logo

Celularity

celularity.com

Cellular Approaches logo

Cellular Approaches

Celvive logo

Celvive

ElevateBio logo

ElevateBio

Platelet BioGenesis logo

Platelet BioGenesis

Encellin logo

Encellin

encellin.com

Cello Therapeutics logo

Cello Therapeutics

cellothera.com

Cellebration Life Sciences logo

Cellebration Life Sciences

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

Cellvie logo

Cellvie

cellvie.bio

Convalesce logo

Convalesce

convalesce.co

Xcell Biosciences logo

Xcell Biosciences

xcellbio.com

HebeCell logo

HebeCell

hebecellcorp.com

Spheringenics logo

Spheringenics

Cellevolve Bio - Quick Facts

Who are Cellevolve Bio's competitors?

Companies similar to Cellevolve Bio include Cell BioEngines, Celularity, Cellular Approaches and Celvive.

When was Cellevolve Bio founded?

Cellevolve Bio was founded in 2020.

Where is Cellevolve Bio's headquarters located?

Cellevolve Bio's headquarters is located in San Francisco, CA, US.

When was Cellevolve Bio's last funding round?

Cellevolve Bio's most recent funding round was for $6M (USD) in November 2021.

How much has Cellevolve Bio raised to-date?

As of Nov 18, 2021, Cellevolve Bio has raised a total of $6M (USD).

How many employees does Cellevolve Bio have?

Cellevolve Bio has 9 employees as of Feb 4, 2024.

Cellevolve Bio - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Licensing
  • Recurring
Customer
  • Enterprise
Main Product
  • Cell Therapy
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified